J Mitra Launches India’s First Dengue NS1 Antigen Self-Test

New Delhi: J Mitra & Company has revitalised its war against dengue by launching the Dengue NS1 Antigen self-test kit. This is the first self-test/home-test kit launched by any company in India.

It detects dengue on the first day of fever; it is self-administrable – anyone can conduct the test on their own and in any location; Results are available within 20 mins.

Using the Dengue NS1 Antigen self-test is a straightforward, 2-step process – add one drop of blood into the sample well; add one drop of assay buffer; allow the reaction to occur for 20 minutes and read the result.

The Dengue NS1 Antigen self-test is a proactive tool that can detect the Dengue NS1 Antigen from Day One as soon as the symptoms appear in patients. This early detection capability empowers individuals to take control of their health and seek timely medical intervention. NS1 Antigen can be detected in both primary and secondary dengue infections. However, NS1 is challenging to detect once anti-NS1 Antibodies appear. NS1 Antigen is present at high concentrations in the sera of Dengue virus-infected patients during the early clinical phase of the disease.

Dengue is amongst the top 10 most communicable diseases in India, and the most affected states include Uttar Pradesh, West Bengal, Bihar, Karnataka, Maharashtra, Kerala, Delhi, Rajasthan, Punjab and Odisha.

Related Posts

  • Pharma
  • January 21, 2025
  • 55 views
Biocon urges govt to exempt cancer, rare-disease drugs from tax in Budget

India should eliminate tax on drugs for cancer treatment and for chronic and rare diseases, the chairperson of major drugmaker Biocon Ltd said ahead of Prime Minister Narendra Modi’s budget…

  • Pharma
  • January 21, 2025
  • 64 views
Glenmark Pharma share rises 2% as unit launches blood clotting drug

Glenmark Pharmaceuticals share price:Pharmaceutical major Glenmark Pharmaceuticals shares rose up to 2.23 per cent to hit an intraday high of Rs 1,537.90 per share on Tuesday, January 21, 2025. The…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Biocon urges govt to exempt cancer, rare-disease drugs from tax in Budget

Biocon urges govt to exempt cancer, rare-disease drugs from tax in Budget

Glenmark Pharma share rises 2% as unit launches blood clotting drug

Glenmark Pharma share rises 2% as unit launches blood clotting drug

Fire breaks out at pharmaceutical company in Andhra Pradesh, no casualty

Fire breaks out at pharmaceutical company in Andhra Pradesh, no casualty

Pharma body to cap prices of cigarette substitutes, seeks data

Pharma body to cap prices of cigarette substitutes, seeks data